Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Vaccination with novel low-molecular weight proteins secreted from Trichinella spiralis inhibits establishment of infection.

Tytuł:
Vaccination with novel low-molecular weight proteins secreted from Trichinella spiralis inhibits establishment of infection.
Autorzy:
Srey MT; Department of Pathology, University of Utah, Salt Lake City, Utah, United States of America.
Taccogna A; School of Health, Sport and Bioscience, University of East London, London, United Kingdom.
Oksov Y; Laboratory of Electron Microscopy, Lindsley F. Kimball Research Institute, New York Blood Center, New York, New York, United States of America.
Lustigman S; Laboratory of Molecular Parasitology, Lindsley F. Kimball Research Institute, New York Blood Center, New York, New York, United States of America.
Tai PY; Department of Pathology, University of Utah, Salt Lake City, Utah, United States of America.
Acord J; Cambridge Healthcare Research, London, United Kingdom.
Selkirk ME; Department of Life Sciences, Imperial College London, London, United Kingdom.
Lamb TJ; Department of Pathology, University of Utah, Salt Lake City, Utah, United States of America.
Guiliano DB; School of Health, Sport and Bioscience, University of East London, London, United Kingdom.
Źródło:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2020 Nov 18; Vol. 14 (11), pp. e0008842. Date of Electronic Publication: 2020 Nov 18 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Original Publication: San Francisco, CA : Public Library of Science
MeSH Terms:
Antibodies, Helminth/*immunology
Antigens, Helminth/*immunology
Helminth Proteins/*immunology
Protozoan Vaccines/*immunology
Trichinella spiralis/*immunology
Trichinellosis/*prevention & control
Animals ; Female ; Larva/immunology ; Mice ; Mice, Inbred BALB C ; Muscles/parasitology ; Rats ; Rats, Sprague-Dawley ; Th1 Cells/immunology ; Th2 Cells/immunology ; Trichinellosis/immunology ; Vaccination ; Vaccines, Synthetic/immunology
References:
Int J Parasitol. 2020 Aug;50(9):697-705. (PMID: 32622688)
Bioinformatics. 2007 Nov 1;23(21):2947-8. (PMID: 17846036)
Bioinformatics. 2012 Feb 15;28(4):464-9. (PMID: 22199388)
J Immunol. 2009 Apr 1;182(7):4005-16. (PMID: 19299698)
Parasit Vectors. 2014 Dec 19;7:600. (PMID: 25522912)
Parasit Vectors. 2018 Dec 5;11(1):625. (PMID: 30518426)
Front Microbiol. 2018 Jul 11;9:1544. (PMID: 30050521)
Int J Parasitol. 2009 Apr;39(5):515-24. (PMID: 18992250)
J Biol Chem. 1992 Aug 25;267(24):17339-46. (PMID: 1512269)
Front Microbiol. 2018 Nov 05;9:2504. (PMID: 30455671)
Emerg Infect Dis. 2011 Dec;17(12):2194-202. (PMID: 22172230)
Parasitol Today. 1998 Aug;14(8):318-23. (PMID: 17040798)
Curr Protoc Bioinformatics. 2003 Feb;Chapter 6:Unit 6.4. (PMID: 18428704)
Immunology. 1995 Dec;86(4):495-8. (PMID: 8567011)
Parasite. 2001 Jun;8(2 Suppl):S48-50. (PMID: 11484381)
Vet Res. 2018 Dec 5;49(1):119. (PMID: 30518422)
Nat Genet. 2011 Mar;43(3):228-35. (PMID: 21336279)
Vet Parasitol. 2020 Apr 19;:109114. (PMID: 32386865)
Mol Biochem Parasitol. 2004 Oct;137(2):277-91. (PMID: 15383298)
Exp Parasitol. 2015 Dec;159:264-73. (PMID: 26545353)
Parasit Vectors. 2018 Sep 6;11(1):499. (PMID: 30189888)
Glycobiology. 1994 Oct;4(5):585-92. (PMID: 7881172)
Trends Parasitol. 2018 Sep;34(9):747-758. (PMID: 30064902)
Infect Immun. 2001 Jun;69(6):3658-62. (PMID: 11349027)
Vet Res. 2018 Jul 13;49(1):59. (PMID: 30001738)
J Parasitol. 1976 Oct;62(5):775-85. (PMID: 978367)
Proteomics. 2005 Nov;5(17):4525-32. (PMID: 16220533)
Res Vet Sci. 2018 Oct;120:4-10. (PMID: 30153649)
J Parasitol. 1993 Aug;79(4):472-82. (PMID: 8331468)
Mol Biochem Parasitol. 1991 Mar;45(1):65-75. (PMID: 2052041)
Parasit Vectors. 2015 Sep 23;8:484. (PMID: 26394626)
Int J Parasitol. 2011 Jul;41(8):881-94. (PMID: 21550347)
Immunology. 1994 Jun;82(2):261-7. (PMID: 7927498)
Parasit Vectors. 2015 Feb 05;8:78. (PMID: 25653126)
WormBook. 2006 Nov 23;:1-21. (PMID: 18050431)
PLoS One. 2015 Aug 19;10(8):e0136189. (PMID: 26288365)
Biomed Res Int. 2014;2014:326860. (PMID: 25250316)
J Mol Biol. 1990 Oct 5;215(3):403-10. (PMID: 2231712)
J Helminthol. 2013 Mar;87(1):24-33. (PMID: 22221593)
Grant Information:
DP2 AI112242 United States AI NIAID NIH HHS; 69334 United Kingdom WT_ Wellcome Trust
Substance Nomenclature:
0 (Antibodies, Helminth)
0 (Antigens, Helminth)
0 (Helminth Proteins)
0 (Protozoan Vaccines)
0 (Vaccines, Synthetic)
0 (excretory-secretory antigen, Trichinella)
Entry Date(s):
Date Created: 20201118 Date Completed: 20210125 Latest Revision: 20210125
Update Code:
20240105
PubMed Central ID:
PMC7673540
DOI:
10.1371/journal.pntd.0008842
PMID:
33206649
Czasopismo naukowe
Trichinella spiralis muscle stage larvae (mL1) produce excretory-secreted products (ESPs), a complex mixture of protein, which are believed to be important for establishing or maintaining an infection niche within skeletal muscle and the intestine. Studies of both whole ESPs and individual cloned proteins have shown that some ESPs are potent immunogens capable of eliciting protective immune responses. Here we describe two novel proteins, Secreted from Muscle stage Larvae SML-4 and SML-5 which are 15 kDa and 12 kDa respectively. The genes encoding these proteins are highly conserved within the Trichinellids, are constituents of mL1 ESP and localized in the parasite stichosome. While SML-5 is only expressed in mL1 and early stages of adult nematode development, SML-4 is a tyvosylated glycoprotein also produced by adult nematodes, indicating it may have a function in the enteral phase of the infection. Vaccination with these proteins resulted in an impaired establishment of adult stages and consequently a reduction in the burden of mL1 in BALB/c mice. This suggests that both proteins may be important for establishment of parasite infection of the intestine and are prophylactic vaccine candidates.
Competing Interests: I have read the journal's policy and the authors of this manuscript have the following competing interests: A. Taccogna is an employee of AstraZeneca and has interests in the company.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies